Skip directly to content

NEWS

Webinar: Good COPs or Bad COPs? Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs)
January 18, 2018 – Every year, PEPFAR meets to discuss their strategy and budget for the following year, and set targets on implementing country operation plans (COPs) to improve the response to HIV/AIDS. This webinar held on Thursday, January 11 provides key information regarding the PEPFAR COPs process and timelines, TB/HIV services covered by PEPFAR, and what civil society and advocates should prioritize for inclusion in COPs.

TAG Mourns the Loss of Mathilde Krim, PhD
January 16, 2018 – TAG mourns the loss of an inspirational, tireless, catalytic leader of our movement. Dr. Krim understood the gravity of the epidemic, in its earliest and darkest days, and was driven by her own remarkable intelligence, fierce commitment to civil rights and social justice, extraordinary social and political networks, and true grit to galvanize funders, scientists, policy leaders, and activists toward a single cause: ending HIV and AIDS as a threat to humanity.

Research Toward a Cure
January 12, 2018 – A regularly updated listing of clinical trials and observational studies related to the research effort to cure HIV infection.

Securing a Tuberculosis-Free Future through the Visionary Research of the CDC’s Tuberculosis Trials Consortium
January 10, 2018 – CRAG, the community advisory board to the Tuberculosis Trials Consortium has produced a useful new brief to raise awareness of the TBTC’s accomplishments, show major advancements in TB care resulting from TBTC studies, and make the case for increasing TB research funding at CDC.

TAG Joins Call to Oppose U.S. Secretary of Health and Human Services Appointment
January 5, 2018 —In advance of a U.S. Senate Committee on Finance hearing on January 9, 2018, TAG and over 60 other civil society organizations issued a statement asking U.S. senators to oppose the confirmation of Alex Azar as Secretary of Health and Human Services.

JOB OPPORTUNITY – TAG Finance Manager
January 5, 2018 — TAG is seeking to hire a Finance Manager who will report to the Deputy Executive Director – Development and Operations (DED-DO). The Finance Manager will ensure timely and accurate development, management, and reporting of TAG's financials.

Ending the HIV/AIDS Epidemic
December 26, 2017 – We now have evidence-based tools for HIV treatment and prevention that are so effective that they could conceivably end the most deadly infectious disease epidemic in modern history. Many community leaders across the United States are calling for just that: an end to the HIV/AIDS epidemic in their cities, their counties, and their states.

Hasty Passage of the Tax and Health Care Bill
December 22, 2017 – With the hasty passage of the tax and health care bill passed along party lines yesterday afternoon, Congress has sent a clear message on how they prioritize communities living with and vulnerable to HIV, tuberculosis (TB), and hepatitis C virus (HCV) in the upcoming mid-term election year.

TAG Statement on Forbidden Words in Budget Documents
December 20, 2017 – Treatment Action Group (TAG) joins the chorus of rational voices expressing outrage at reports that HHS agencies have received instructions to avoid words unpalatable to the Trump administration in their budget requests.

TAG Statement to Human Rights Council on Human Rights Concerns in the UAE
December 18, 2017
 – On December 13, 2017, TAG participated in a hearing in Geneva, Switzerland to brief members of the Human Rights Council on human rights concerns in the United Arab Emirates (UAE).

Webinar: Exploring the Implications of the Delamanid Phase III and STREAM Trial Results
December 14, 2017
 – The first ever phase III trials for multidrug-resistant TB (MDR-TB) finally yielded results. Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) presented the results in a Webinar held on December 12, 2017.

2017 Symposium: Reframing Risk and Accountability for Action to ZERO TB
December 14, 2017
– On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health.

HIV Cure Research Information Sheet
December 14, 2017
 – A TAG information sheet on the current state of research into curing HIV infection. 

TAGline Fall 2017
NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS

Sign the Declaration Calling for Drug Decriminalization to Achieve Hepatitis Elimination
December 4, 2017 – At the World Hepatitis Summit in São Paulo, Brazil, a large coalition of hepatitis patients, representatives of the drug using community, medical providers, researchers, and public health experts expressed their whole-hearted support to the commitment of the World Health Organization (WHO)’s goal to eliminate viral hepatitis by 2030. 

Changing World Health Organization Global TB Program Leadership
December 1, 2017
– TAG's Executive Director, Mark Harrington, congratulates Dr. Mario Raviglione on his retirement and thanks him for his efforts and the years of collaboration while he was director of the World Health Organization’s (WHO's) Global TB Program.

TAGupdate
December, 2017 – TAG's progress on the fight to end HIV/AIDS, viral hepatitis, and tuberculosis.

Suboptimal Immune Recovery on Antiretroviral Therapy: Causes, Consequences, & the Search for Solutions
November 29, 2017 – Video and slides from a webinar presented by TAG's Basic Science, Vaccines and Cure Project Director Richard Jefferys and Nelson Vergel from the Program for Wellness Restoration. 

Remarks by Erica Lessem on TB research at the WHO Global Ministerial Conference on Ending TB
November 27, 2017
– In remarks delivered at the first-ever WHO Global Ministerial Conference on Ending Tuberculosis (TB), TAG's Deputy Executive Director of the TB Project, Erica Lessem, describes the urgent need for civil society to drive political action on funding TB R&D, by drawing from lessons and successes of the HIV movement.

The Ascent Begins: Tuberculosis Research Funding Trends, 2005–2016
November 8, 2017 – Global funding for TB research reached a previously unreported high of $726 million in 2016, according to TAG's latest Tuberculosis Research Funding Trends report. This represents a $100 million increase over 2015 levels and marks the first time annual funding for TB research and development (R&D) has exceeded $700 million since TAG began tracking spending in 2005. Although higher than in previous years, this amount remains woefully inadequate when judged against the innovation gaps holding back the response to TB, which is the world’s leading cause of death from a single infectious agent.

End the Epidemic Resources: Southern States EtE Meeting Summary and FAQs
November 2, 2017 – In May, TAG, the Southern AIDS Coalition, the Southern HIV/AIDS Strategy Initiative, Sisterlove, and AIDS Alabama, and the National Alliance of State and Territorial AIDS Directors (NASTAD) held a consultation with more than 40 community advocates and key stakeholders from across the Deep South to assess the major challenges and opportunities for EtE planning. Several key findings from that meeting can be found in this summary report. Included here is a document addressing the frequently asked questions we often get about the EtE campaigns.
 
Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics
October 31, 2017 – A summary of the July 2017 Hepatitis C World Community Advisory Board meeting on the HCV landscape and the significant barriers—such as financing, awareness, complicated and unaffordable diagnostics, centralized service delivery, and stigma—that obstruct the sustainable scaling up of prevention, testing, and treatment services.
 
US Health & Human Services (HHS) Strategic Plan FY 2018-2022: TAG Comments to the Assistant Secretary for Planning and Evaluation
October 27, 2017 – TAG comments submitted to the Strategic Planning Team at the Office of the Assistant Secretary for Planning and Evaluation regarding the HHS Strategic Plan FY 2018-2022. The HHS Strategic Plan should set a precedent for reducing the burden of disease nationally through its focus on access to affordable treatment, advancement of research, implementation of evidence-based interventions, expansion of populations served, and inclusion of all stakeholders.
 
Tools to help support activists in engaging national policy makers on TB
October 25, 2017 - Two unprecedented political opportunities are rapidly approaching– the Global Ministerial Conference and the UN High Level Meeting on TB. Civil society and community groups have a critical role to play in raising the profile and understanding of the issues we face in TB among government officials and ensuring that the commitments they make at high-level meetings are translated into urgent investments and actions. To facilitate engagement between civil society and community groups and national policy makers, TAG has created tools and resources to help support grassroots efforts.


Submission to the Office of the United Nations High Commissioner for Human Rights to Report on Sustainable Development Goals and Health
October 16, 2017 – A review of comments submitted by TAG to the Office of the United Nations High Commissioner for Human Rights, in response to a request for submissions from interested organizations and stakeholders for the preparation of its report on Sustainable Development Goals and Health.

TAG HIV Basic Science, Vaccines, and Cure Project Blog Updates
October 12, 2017 – Effects of the anti-inflammatory antibody canakinumab on heart disease and cancer. Are there implications for HIV?

JOB OPPORTUNITY: TAG Deputy Executive Director – Development and Operations
October 4, 2017 – TAG seeks a Deputy Executive Director for Development and Operations who will report directly to and work closely with the Executive Director, the senior staff, the administrator, other staff and consultants, and the Board of Directors and its committees.Applicant CV, letter of interest, salary requirement, and references should be submitted no later than Friday, October 27, 2017.

Take Action: #StopRTT Social Media Advocacy Toolkit
October 3, 2017 – Join TAG and our partners and take action by tweeting at members of the House of Representatives Energy & Commerce Subcommittee on Health to urge that they withdraw their support and block dangerous "Right to Try" bills (H.R. 1020) from advancing. Your Representatives need to hear from you! 

Letter to House E&C Subcommittee Opposing "Right to Try" Bills
October 3, 2017 – Right-to-Try legislation does nothing for people who are terminally ill. It instead aims to curtail vital FDA stringency requirements that have not only largely succeeded in protecting public health, but continue to be effectively streamlined to hasten access to investigational and approvable drugs and biologics for those who need them most.

HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials
September 27, 2017 – A new paper from TAG on the questions surrounding implementation of Truvada pre-exposure prophylaxis (PrEP) in clinical trials of biomedical prevention interventions. 

TAG Applauds Malaysian Government's Decision to Make Generic form of Life-Saving Hep C Cure
September 20, 2017 The Government of Malaysia reaffirmed its commitment to affordable access to hepatitis C treatment by issuing a compulsory license on sofosbuvir (Sovaldi). TAG lauds this landmark decision for enabling the entry of generic competition, which will effectively reduce prices.

September 11, 2017 - The Activist's Guide to the TB LAM Test is written to help support advocacy and activism efforts aimed at  encouraging the uptake of the LAM test across regulatory agencies, donor-funded programs, and National AIDS and TB Progams. This guide discusses LAM as a critically important, true point-of-care diagnostic designed to detect TB in people living with HIV (PLHIV) with low CD4 counts. While providing strategies and messaging to ensure access to this vital diagnostic for people living with both HIV and TB. 
 
Division of AIDS Clinical Trials Networks Recompetition for 2020–2027 – Comments and Recommendations from TAG
August 28, 2017 – Final letter submitted to Director Carl Dieffenbach, PhD, in advance of the recompetition of the Division of AIDS clinical trials networks for the 2020 to 2027 funding cycle. A link to Director Dieffenbach's August 31, 2017, response is provided.
 
Advocacy Organizations Celebrate Results as UnitedHealthCare Reverses Discriminatory PrEP Practices; Urge Other Insurers to Follow Suit
August 8, 2017 - TAG along with fourteen health and social justice organizations from across the U.S. celebrate the people-powered effort behind UnitedHealthcare responding so swiftly to demands that they improve access to the HIV drug Truvada for pre-exposure prophylaxis (PrEP), a medical intervention that prevents HIV infection. On Friday, Aug. 4, UnitedHealthcare received a joint letter from this coalition objecting to new prior authorization rules put in place for access to PrEP effective July 1. Read more here.
 
Community Calls On United Healthcare to End Discriminatory Prior Authorization Practices for PrEP Access
August 4, 2017
  14 organizations, along with TAG, sent a community letter to United Healthcare (UHC) calling on the insurer to end discriminatory practices in regards to patient access for Pre-exposure Prophylaxis (PrEP) for HIV prevention. Specifically, UHC has been requiring documentation for prior authorization every three months for Truvada, prescribed for PrEP. Advocates cite such practices as a violation of the Affordable Care Act's non-discrimination policies and a barrier to accessing a vitally important prevention tool for vulnerable communities. Furthermore, denial letters that are being sent contain inappropriate and judgemental language that questions UHC members' sexual orientation, HIV status and/or drug use, which only continues to perpetuate stigma and discrimination. 
 
TAG Opposes the Right to Try Act that Uneccessarily Dangers Patients and Diminishes the FDA's Role
August 2, 2017  TAG joined partner organizations in signing on to a letter opposing S.204, "Right to Try Act 2017", as an amendment to pending legislation on FDA user-fee programs. This amendment needlessly puts patients at risk through diminishing the role of FDA in ensuring the safety and effectiveness of treatments before they are made widely available. Rather, established pathways such as the FDA's Expanded Access Program can already enhance access and uphold patient rights, while balancing the need for continued clinical testing and development of experimental drugs and devices. 
 
HIV Remission News from IAS 2017
July 25, 2017  Coverage from the 9th International AIDS Society Conference on HIV Science via TAG's HIV Basic Science, Vaccines, and Cure Project Blog.
 
Take Action to Help Prioritize TB Research for Pregnant Women 
July 25, 2017
  On August 21-22, the newly-formed Taskforce on Research Specific to Pregnant and Lactating Women (PRGLAC) will be meeting for the first time. This taskforce will advise the Secretary of the U.S. Department of Health and Human Services (HHS) on ways the government can fill knowledge gaps for pregnant women. Join TAG in an effort to help prioritize research for pregnant women with TB, by signing on to a community comment to PRGLAC on strategies the U.S. government can take to support research and researchers focused on meeting the needs of this vulnerable population. Deadline to sign-on is August 14.
 
Sign-on Letter in Response to Critical Shortage of Penicillin for Syphilis Treatment in U.S.
June 22, 2017 – A sign-on letter urging Pfizer to adequately and promptly address the penicillin G benzathine (Bicillin-LA) shortage to ensure normal quantities in the United States. Bicillin-LA remains the preferred treatment for primary and secondary syphilis in adults, infants, and children, and the only approved treatment for syphilis in pregnant women. As the only manufacturer of pencillin G benzathine in the United States, Pfizer’s inability to provide adequate quantities of Bicillin-LA has left the FDA, CDC, and many city and state health departments scrambling to ration existing stockpiles of the drug and develop contingency plans.

TAG's 2016 Annual Report
June 14, 2017 –  Ending the Epidemic - Progress in the Fight for Better Treatment, a Vaccine, and a Cure for AIDS.  Read TAG's 2016 Annual Report. 
 
#SaveFogarty Social Media Advocacy Toolkit: Help save HIV, TB, HCV and global health research supported by the Fogarty International Center at NIH​
June 14, 2017 – Join HIV Medicine Association (HIVMA), Infectious Diseases Society of America (IDSA) and Treatment Action Group (TAG) in an effort to #SaveFogarty through a social media toolkit to build community support for the Fogarty International Center during the LHHS appropriations subcommittee hearing, highlight how cuts to Fogarty hurt research conducted by state institutions and urge Congress to save it from elimination. Your Senators need to hear from you!
 
TAG Responds to CBS Sunday Morning's Shameful AIDS Anniversary Coverage
June 6, 2017
  To commemorate the 36th anniversary of public health officials’ discovery of the AIDS pandemic, CBS Sunday Morning gave viewers more of the same narrative they’ve been hearing for nearly four decades. The segment, “36 Years and Counting: AIDS in America,” reported by Rita Braver, painted the epidemic’s heroes as white gay men, and its problem as the rest of us, particularly gay men of color, whose irresponsible behavior has blocked progress in ending the epidemic here in the United States.  By repeating these same tropes and myths about the AIDS crisis as an epidemic fueled by irresponsible people, the media has once again failed to explain larger systemic failures.  Read the entire commentary at Rewire News.
 
TAG Earns Top-Ranking 4-Star Rating From Charity Navigator
June 6, 2017
TAG’s strong financial health and commitment to accountability and transparency have earned it a 4-star rating from Charity Navigator, America’s largest independent charity evaluator.This is the second consecutive year that TAG has earned this top distinction
 
TAG Condemns Murderous White House-Proposed 2018 Budget Cuts for Health and Research​
May 24, 2017  The full disclosure of President Trump's FY18 budget yesterday reaffirms the current administration's intention of scaling-back critical progress in programs and research made in the fight against HIV/AIDS, TB, HCV, and other domestic and global health issues. Treatment Action Group, alongside many partner organizations, calls on all members of Congress to immediately ensure these proposed cuts are dead on arrival.
 
House to People Living with HIV, HCV and TB: “Drop Dead”
May 4, 2017 – TAG condemns the passage of the American Health Care Act (AHCA) today by the House of Representatives and calls for critical community action as the dangerous bill now heads to Senate.

HIV Cure Research: CROI 2017 Update Webinar
May 3, 2017 - Treatment Action Group and DARE Collaboratory Community Advisory Board community webinar on HIV cure research results presented at the 2017 Conference in Retroviruses and Opportunistic Infections (CROI).

This #MayDay, Join the HIV Community Movement for Expanded Sanctuary
May 1, 2017 – A Joint Statement from Counter Narrative Project, HIV Prevention Justice Alliance, Positive Women's Network - USA, TransLatin@ Coalition, Treatment Action Group, the US People Living with HIV Caucus and Venas Abiertas  Sign on here.
 
TAGline Spring 2017
NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS